Skip to main content

Advertisement

Log in

Uncertain Future of Trials in Osteoporosis

  • Review Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract:

The advent of effective agents for the treatment of osteoporosis has led to the view that placebo-controlled trials to test new agents for efficacy are no longer appropriate since proven treatments are available. In this review we argue that, if new agents are to be developed, there is still a place for the placebo-controlled trial. A move to studies of equivalence or non-inferiority raises more problems than it resolves.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 19 December 2001 / Accepted: 11 March 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanis, J., Oden, A., Johnell, O. et al. Uncertain Future of Trials in Osteoporosis. Osteoporos Int 13, 443–449 (2002). https://doi.org/10.1007/s001980200052

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001980200052

Navigation